| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.9M | — | +287.1% |
| Cost of Revenue | $973K | — | +138.5% |
| Gross Profit | $947K | — | +976.1% |
| R&D Expense | $3.2M | — | -22.5% |
| SG&A Expense | $2.7M | — | +5.1% |
| Operating Income | -$6.1M | — | +20.8% |
| Interest Expense | $1.8M | — | +69.1% |
| Pre-tax Income | -$9.7M | — | -41.9% |
| Income Tax | $128K | — | +21.9% |
| Net Income | -$9.9M | — | -41.6% |
| EPS (Basic) | -$0.15 | — | +0.0% |
| EPS (Diluted) | -$0.15 | — | +0.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $7.2M | +1117.8% | +591.5% |
| Accounts Receivable | $2.4M | -7.0% | -46.8% |
| Inventory | $1.6M | +64.5% | -50.1% |
| Current Assets | $19.0M | +60.2% | +23.5% |
| Total Assets | $22.4M | +43.0% | +28.0% |
| Current Liabilities | $74.5M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$7.4M | — | +6.6% |
| Capital Expenditures | $65K | — | -44.9% |
| Investing Cash Flow | -$65K | — | +44.9% |
| Financing Cash Flow | $14.1M | — | +83.7% |
| Free Cash Flow | -$7.5M | — | +7.1% |
| +4.4% |
| Long-term Debt | $57.7M | -7.8% | +15.0% |
| Total Liabilities | $96.3M | -2.7% | +15.9% |
| Stockholders' Equity | -$73.9M | +11.2% | -12.7% |